Literature DB >> 8474071

Synovial type (group II) phospholipase A2 in cartilage.

T J Nevalainen1, F Märki, P T Kortesuo, M G Grütter, S Di Marco, A Schmitz.   

Abstract

Phospholipase A2 (PLA2) was produced in E. coli by a recombinant technique using a synthetic gene coding for PLA2 found in synovial fluid (SF) of patients suffering from rheumatoid arthritis (RA). Polyclonal antibodies were produced against the recombinant synovial type PLA2 (syn-PLA2) in a rabbit. The IgG fraction of the antiserum was isolated and the specificity was tested by immunoblotting. The antiserum detected a protein with an apparent molecular weight of 15 kDa in extracts of cartilage, but did not react with PLA2 isolated from human pancreas or ascitic fluid. In immunohistochemistry, the anti-syn-PLA2 antibody decorated chondrocytes and matrix of articular, laryngeal and auricular cartilage, but did not decorate synovial tissue or its contained inflammatory cells in RA or other human tissues tested (pancreas, liver, thyroid, tonsil, lung, nasal polyp, skin, placenta, myometrium, bone). The results show that syn-PLA2 is present both in articular and extraarticular cartilage and support the view that PLA2 found in SF might originate from chondrocytes, and not from synovial lining or inflammatory cells.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474071

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  11 in total

1.  Distribution of pancreatic (group I) and synovial-type (group II) phospholipases A2 in human tissues.

Authors:  T J Nevalainen; T J Haapanen
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

2.  Gene expression of group II phospholipase A2 in intestine in ulcerative colitis.

Authors:  M M Haapamäki; J M Grönroos; H Nurmi; K Alanen; M Kallajoki; T J Nevalainen
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

3.  In vivo and in vitro studies of cytosolic phospholipase A2 expression in Helicobacter pylori infection.

Authors:  G Nardone; E L Holicky; J R Uhl; L Sabatino; S Staibano; A Rocco; V Colantuoni; B A Manzo; M Romano; G Budillon; F R Cockerill; L J Miller
Journal:  Infect Immun       Date:  2001-09       Impact factor: 3.441

4.  Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis.

Authors:  Suet Y Leung; Xin Chen; Kent M Chu; Siu T Yuen; Jonathan Mathy; Jiafu Ji; Annie S Y Chan; Rui Li; Simon Law; Olga G Troyanskaya; I-Ping Tu; John Wong; Samuel So; David Botstein; Patrick O Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2002-11-27       Impact factor: 11.205

5.  The expression and distribution of group IIA phospholipase A2 in human colorectal tumours.

Authors:  Tuulia Avoranta; Jari Sundström; Eija Korkeila; Kari Syrjänen; Seppo Pyrhönen; Jukka Laine
Journal:  Virchows Arch       Date:  2010-10-12       Impact factor: 4.064

6.  Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma.

Authors:  Jiazhong Jiang; Blake Lee Neubauer; Jeremy R Graff; Marcio Chedid; James E Thomas; Neal W Roehm; Shaobo Zhang; George J Eckert; Michael O Koch; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

7.  Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations.

Authors:  Saida Mebarek; Abdelkarim Abousalham; David Magne; Le Duy Do; Joanna Bandorowicz-Pikula; Slawomir Pikula; René Buchet
Journal:  Int J Mol Sci       Date:  2013-03-01       Impact factor: 5.923

8.  Increased expression of human type IIa secretory phospholipase A2 antigen in arthritic synovium.

Authors:  O S Jamal; P G Conaghan; A M Cunningham; P M Brooks; V F Munro; K F Scott
Journal:  Ann Rheum Dis       Date:  1998-09       Impact factor: 19.103

9.  Increased group II phospholipase A2 in colonic mucosa of patients with Crohn's disease and ulcerative colitis.

Authors:  T Minami; H Tojo; Y Shinomura; Y Matsuzawa; M Okamoto
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

10.  Expression of human group II PLA2 in transgenic mice results in epidermal hyperplasia in the absence of inflammatory infiltrate.

Authors:  D S Grass; R H Felkner; M Y Chiang; R E Wallace; T J Nevalainen; C F Bennett; M E Swanson
Journal:  J Clin Invest       Date:  1996-05-15       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.